Saturday, September 23, 2023
Saturday, September 23, 2023

Jupiter Medical Center Appoints Dr. Charles Murphy as Chief Quality and Patient Safety Officer

Dr. Charles Murphy: Jupiter Medical Center, the number one ranked hospital for safety, quality and patient satisfaction in Palm Beach County and the Treasure Coast region, today announced the appointment of Charles Murphy, Jr., MD, CPPS as Chief Quality and Patient Safety Officer.

Previously, Dr. Murphy served as associate chief patient safety officer and medical director of intensive care units at Duke University Health System. Under his leadership, all three acute care hospitals in the Duke Health system received ‘A’ safety grades from The Leapfrog Group for providing the highest standard in patient safety and quality. In 2014, Dr. Murphy was selected by the American Hospital Association – National Patient Safety Foundation Safety Leadership for fellowship. He also received an award for Most Improved Patient Safety Culture from Cardiothoracic Surgery Collaborative at Duke Hospital.

“We are delighted to welcome Dr. Murphy in leading our patient safety and quality initiatives,” said Dr. Amit Rastogi, president and CEO of Jupiter Medical Center. “Aside from his remarkable experiences in leading safety and quality initiatives at world-class health systems, including Duke University Health System and Inova, Dr. Murphy will bring a physician’s perspective to how we continuously improve our patient experience and outcomes.”

Dr. Murphy most recently served as chief patient safety officer at the Inova Heart and Vascular Institute based in Falls Church, Virginia. During his four-year tenure, he attained 20 to 30 percent reductions in patient harm year over year. His leadership at Inova resulted in achieving a two percent improvement in the hospital’s Agency for Healthcare Research and Quality (AHRQ) safety culture scores from 2017 to 2019 and expanded the Extracorporeal Membrane Oxygenation (ECMO) program from 10 to 100 cases per year as the Executive Leader. He also spearheaded the development of a multidisciplinary shock team with an increase in survival from 50 to 70 percent.

“I am pleased to join Jupiter Medical Center, Palm Beach County’s number one ranked hospital for quality, safety and patient satisfaction,” said Charles Murphy, Jr., MD, CPPS. “We will continue to build on Jupiter Medical Center’s well-deserved reputation and unwavering commitment to providing the highest standards of patient care.”

Since 2014, Murphy has served as a Board Member for the Foundation for the Advancement of Cardiovascular And Thoracic Critical Care. He has received certifications from the American Board of Surgery, American Board of Thoracic Surgery, American Board of Surgery Surgical Critical Care, and Board for Professionals in Patient Safety. Dr. Murphy is also a member of several highly-regard professional medical committees, including the Society of Critical Care Medicine, Society of Thoracic Surgery, Foundation for the Advancement of Cardiovascular And Thoracic Critical Care, American Society of Professionals in Patient Safety, American Association of Physician Leadership, among others.

Murphy earned a Doctor of Medicine from Duke University School of Medicine in Durham, North Carolina, and a Bachelor of Science with honors in Biology from Loyola University, New Orleans. Dr. Murphy received his post-graduate training at Duke University Medical Center.

In May of 2020, Jupiter Medical Center announced it had been awarded an ‘A’ safety grade rating and is the only hospital in Palm Beach County to earn the top rating for the Spring of 2020. The ‘A’ safety rating awarded by The Leapfrog Group, a national nonprofit focused on rating and measuring hospital safety, quality and affordability, is considered ‘the gold standard measure of patient safety.’ The Leapfrog Group has also recognized Jupiter Medical Center as a “Top Hospital,” an annual distinction earned by only six percent of hospitals nationwide. Additionally, Jupiter Medical Center remains the only hospital in Palm Beach, Martin, St. Lucie and Indian River counties to receive a 4-star safety and quality rating from the Centers for Medicare & Medicaid Services (CMS).

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

FDA OK’s ensoETM for Use in Cardiac Ablations to Reduce Risk of Esophageal Injury

Published studies that have examined the use of ensoETM for this purpose include the pilot eCOOL-AF study, the IMPACT study and a large multi-center analysis of over 25,000 patients (in press at the Journal of the American College of Cardiology: Clinical Electrophysiology). These studies have found up to an 83 percent reduction in esophageal injuries, and a significant reduction in risk of atrioesophageal fistula (AEF), one of the most dreaded complications of ablation procedures. Receives FDA Clearance and Breakthrough Device Designation has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy